Sally de Boer
Overview
Explore the profile of Sally de Boer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li A, Teoh A, Troy L, Glaspole I, Wilsher M, de Boer S, et al.
Thorax
. 2024 Sep;
79(11):1024-1032.
PMID: 39317451
Background: Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative (GLI) reference equations...
2.
Mackintosh J, Keir G, Troy L, Holland A, Grainge C, Chambers D, et al.
Respirology
. 2024 Jan;
29(2):105-135.
PMID: 38211978
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA)...
3.
Assayag D, Adegunsoye A, Sheehy R, Morisset J, Khalil N, Johannson K, et al.
Chest
. 2023 Jan;
163(5):1156-1165.
PMID: 36621759
Background: Biological sex, gender, and race are important considerations in patients with interstitial lung diseases (ILDs). Research Question: Does a patient's sex assigned at birth, and race, influence ILD treatment...
4.
Cardiorespiratory responses to muscle metaboreflex activation in fibrosing interstitial lung disease
Chen C, Kolbe J, Wilsher M, de Boer S, Paton J, Fisher J
Exp Physiol
. 2022 Mar;
107(5):527-540.
PMID: 35298060
New Findings: What is the central question of this study? We determined whether sensory feedback from metabolically sensitive skeletal muscle afferents (metaboreflex) causes a greater ventilatory response and higher dyspnoea...
5.
Jee A, Sheehy R, Hopkins P, Corte T, Grainge C, Troy L, et al.
Respirology
. 2020 Nov;
26(1):23-51.
PMID: 33233015
Pulmonary complications in CTD are common and can involve the interstitium, airways, pleura and pulmonary vasculature. ILD can occur in all CTD (CTD-ILD), and may vary from limited, non-progressive lung...
6.
Jo H, Prasad J, Troy L, Mahar A, Bleasel J, Ellis S, et al.
Med J Aust
. 2018 Feb;
208(2):82-88.
PMID: 29385965
Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease associated with debilitating symptoms of dyspnoea and cough, resulting in respiratory failure, impaired quality of life and ultimately death. Diagnosing...
7.
de Boer S, Lewis C, Fergusson W, Ellyett K, Wilsher M
Intern Med J
. 2018 Jan;
48(7):845-850.
PMID: 29345411
Background And Aims: This study evaluated whether there are ethnic factors which affect the severity and progression of bronchiectasis in our adult multi-ethnic population in Auckland, New Zealand. Methods: Clinical...
8.
Jo H, Troy L, Keir G, Chambers D, Holland A, Goh N, et al.
Respirology
. 2017 Aug;
22(7):1436-1458.
PMID: 28845557
Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease (ILD) of unknown aetiology with a median survival of only 2-5 years. It is characterized by progressive dyspnoea and worsening...
9.
de Boer S, Kolbe J, Wilsher M
Respirology
. 2014 Aug;
19(7):1019-24.
PMID: 25123812
Background And Objectives: Dyspnoea is a common symptom in sarcoidosis and is not predictably related to pulmonary function or radiology. A subjective symptom of dyspnoea is likely to be influenced...
10.
de Boer S, Kolbe J, Wilsher M
Respirology
. 2014 Mar;
19(4):604-7.
PMID: 24666931
Background And Objective: Dyspnoea and exercise intolerance are common in sarcoidosis and are often poorly correlated with resting lung function. Measurement of peak exercise capacity is likely to be helpful...